Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
“No but I predict there will be a PR on or about January 9th.”
Know the game. Stock will rise today with volume. MFO is converting to market. We still need time for a deal.
SS is a buyer. Welcome.
It’s called desensitization from nonsense.
Welcome back LoanArranger.
Unnoticed?
This is boring.
What am I accomplishing by calling?
Clorox? I have gasoline poured and a match ready to be lit. It might get real hot in here.
You’re saying you’d rather have Aspire? Are you trying a new diatribe to try and convince investors the MFO is to blame? What’s your motivation here?
MFO is necessary to bridge financing until a deal. None of your silly diatribe will be able to motivate others differently. I am not arguing with different aliases anymore. Your silly arguments will make me bring out some other truths that might nip a few buds. Respond and let the games begin.
Who’s funds are currently keeping IPIX solvent? Please enlighten me.
Want to argue about it?
Happy Armenian Christmas to you guys. You know who you are. Wink wink.
Yes, the entity keeping the company solvent is the problem. Fly on Dodo.
Sometimes patience is the key to victory. Where are all our resident Dodo Birds? Seems they’ve started their migration to other pastures. Good riddance.
Neither do I. Where’s the Loan Arranger to chime in for his underwriting expertise?
Stock incentives. He knows the value potential. Com’on Lone Range!
No but I predict there will be a PR on or about January 9th.
He has plenty of shares and understands his salary is detrimental and LW will handle the transactions.
All aboard! The train to circumnavigate a hole of nothingness is leaving the station.
Right again. I knew today would warrant a very high percentage. Know the game.
Opinion:
Based on current volume and price, we will see a very high percentage today from AlanC. Prices are too low to sell, MMs are trying to use slight dip and high volume to shake shares. Come down a little more, I need another couple of hundred thousand shares. No one is jumping ship.
Very astute. It’s about share count. Insiders holding or unloading are the key indicators. Everyone has kept or increased their shares to date.
Opinion:
Dr. B is a dermatologist by trade. He was brought on during a time when a dermatological indication for B was the focus to drive this asset and company forward. The business model has changed and B-OM, B for GI indications and eventually K will be the driving forces. Locust Walk was brought on to create a deal for B-OM and they fit better than a Dermatologist. The position of the company moving forward brings the need for someone who can explain the science of the main indications to create a deal now that ABSSSI hasn’t been the focus for some time.
If IPIX brings on the best doctor in the world for Gastrointestinal diseases, Mark my words, people will dilute his or hers credentials and praise Dr. B in the same way they destroyed Menon then spoke of his praises after departure.
Nature of the beast. Company focuses change, Chiefs get replaced. New coaches sometimes bring on new dynasties. Others run the same unlit torch a few more miles. I think everyone here realizes change is good. We can’t go down much further but the sky is very high!
Rhetorical in nature once again. We do not know why he left. He could have picked 2020 as his retirement year a decade ago. It’s pure speculation until the company gives further insight, if they see fit. Until news of money, partnership, buyout, etc. this stock stays down here.
His position was to play any position on the field that needed to be played. That includes helping to coordinate, negotiate and finalize deals. No one is wrong so stop it.
Spin? I want to see share counts when available. How do you spin this?
No need to make anything material at this point. Ho Ho Ho.
Surprise indeed. You’re just not privy to the surprises.
“If we see that B targets the right area of the GI they will be knocking down our doors.”
B-OM is a valuable asset and will not be used as the indication to move IPIX along financially. It will be used as the company maker when the time is right. IMO!
Exact opposite, no one is buying in large amounts or selling in large amounts. This is the phase that MMs maintenance volume and delivery. But you know this.
ENT - Ear, Nose, Throat is a different specialist to a GI doctor. B-OM is NOT included in SA’s first rights.
Learn the game and you have a better chance of winning.
No they do not. B-OM is considered a possible company maker and not a part of that scenario. B-UC and Crohn’s would be part of the negotiating scenario. BDD will or has helped show the tablets reached the proper location of the GI tract for specific indications thereby leading to a sucessful trial determination to the proper regulatory agency where the phase 1 trial is being held.
What do you want to spin here?
Can’t be a bad thing either way. Nothing to spin here.
What point are you talking about? They erase my posts so I don’t know what you’re referring to.
My friend who introduced me to IPIX sent me a link of some pretty decent information regarding some updated info on the test with BDD. I’m not sure if he wants me to share.